|
US2917432A
(en)
|
1954-10-05 |
1959-12-15 |
Burroughs Wellcome Co |
Leukemia treatment
|
|
US3046301A
(en)
|
1959-10-29 |
1962-07-24 |
Burroughs Wellcome Co |
Method of making chlorambucil
|
|
GB1354939A
(en)
|
1971-10-28 |
1974-06-05 |
Ici Ltd |
Process for the manufacture of 1,1,2-triphenylalk-1-enes
|
|
US4005063A
(en)
|
1973-10-11 |
1977-01-25 |
Abbott Laboratories |
[Des-gly]10 -GnRH nonapeptide anide analogs in position 6 having ovulation-inducing activity
|
|
GB1524747A
(en)
|
1976-05-11 |
1978-09-13 |
Ici Ltd |
Polypeptide
|
|
US4282361A
(en)
*
|
1978-03-16 |
1981-08-04 |
Massachusetts Institute Of Technology |
Synthesis for 7-alkylamino-3-methylpyrazolo [4,3-d]pyrimidines
|
|
DE2845574A1
(de)
|
1978-10-19 |
1980-04-24 |
Deutsches Krebsforsch |
Durch heterocyclische ringe oder alkylreste substituierte analoga von ccnu und verfahren zu deren herstellung
|
|
ATE28864T1
(de)
|
1982-07-23 |
1987-08-15 |
Ici Plc |
Amide-derivate.
|
|
US4666828A
(en)
|
1984-08-15 |
1987-05-19 |
The General Hospital Corporation |
Test for Huntington's disease
|
|
US4683202A
(en)
|
1985-03-28 |
1987-07-28 |
Cetus Corporation |
Process for amplifying nucleic acid sequences
|
|
US4801531A
(en)
|
1985-04-17 |
1989-01-31 |
Biotechnology Research Partners, Ltd. |
Apo AI/CIII genomic polymorphisms predictive of atherosclerosis
|
|
US4978672A
(en)
|
1986-03-07 |
1990-12-18 |
Ciba-Geigy Corporation |
Alpha-heterocyclc substituted tolunitriles
|
|
JPS6425763A
(en)
|
1987-04-24 |
1989-01-27 |
Mitsubishi Chem Ind |
Pyrazoles and insecticide and acaricide containing said pyrazoles as active ingredient
|
|
US5164196A
(en)
|
1987-05-19 |
1992-11-17 |
Ventech Research, Inc. |
Crotoxin complex as cytotoxic agent
|
|
EP0308020A3
(en)
|
1987-09-18 |
1990-12-05 |
Merck & Co. Inc. |
5-(aryl and heteroaryl)-6-(aryl and heteroaryl)-1,2-dihydro-2-oxo 3-pyridinecarboxylic acids and derivatives thereof
|
|
US5002755A
(en)
|
1988-02-18 |
1991-03-26 |
Vanderbilt University |
Method of controlling nephrotoxicity of anti-tumor plaintum compounds
|
|
US5272057A
(en)
|
1988-10-14 |
1993-12-21 |
Georgetown University |
Method of detecting a predisposition to cancer by the use of restriction fragment length polymorphism of the gene for human poly (ADP-ribose) polymerase
|
|
US5192659A
(en)
|
1989-08-25 |
1993-03-09 |
Genetype Ag |
Intron sequence analysis method for detection of adjacent and remote locus alleles as haplotypes
|
|
WO1991018599A2
(de)
|
1990-05-26 |
1991-12-12 |
Byk Gulden Lomberg Chemische Fabrik Gmbh |
1,4-dihydropyridine zur anwendung bei der überwindung von arzneimittelresistenzen
|
|
FR2665898B1
(fr)
|
1990-08-20 |
1994-03-11 |
Sanofi |
Derives d'amido-3 pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant.
|
|
IL100110A0
(en)
|
1990-12-26 |
1992-08-18 |
American Cyanamid Co |
Insecticidal and synergistic miticidal compositions
|
|
PL170837B1
(pl)
|
1991-10-18 |
1997-01-31 |
Monsanto Co |
S rod ek g r zybobó j c zy PL PL PL PL PL PL
|
|
DK0752248T3
(da)
|
1992-11-13 |
2000-11-13 |
Idec Pharma Corp |
Terapeutisk anvendelse af kimæriske og radioaktivt mærkede antistoffer mod humant B-lymfocytbegrænset differentieringsantig
|
|
CZ284157B6
(cs)
|
1992-12-17 |
1998-08-12 |
Pfizer Inc. |
Pyrazolové a pyrazolopyrimidinové sloučeniny jako takové a pro léčbu chorob a farmaceutické prostředky na jejich bázi
|
|
JP3156026B2
(ja)
|
1993-12-27 |
2001-04-16 |
株式会社大塚製薬工場 |
ホスホン酸ジエステル誘導体
|
|
US5773001A
(en)
|
1994-06-03 |
1998-06-30 |
American Cyanamid Company |
Conjugates of methyltrithio antitumor agents and intermediates for their synthesis
|
|
WO1996014843A2
(en)
|
1994-11-10 |
1996-05-23 |
Cor Therapeutics, Inc. |
Pharmaceutical pyrazole compositions useful as inhibitors of protein kinases
|
|
US5502068A
(en)
|
1995-01-31 |
1996-03-26 |
Synphar Laboratories, Inc. |
Cyclopropylpyrroloindole-oligopeptide anticancer agents
|
|
GB9514380D0
(en)
|
1995-07-13 |
1995-09-13 |
Knoll Ag |
Therapeutic agents
|
|
EP0951541B1
(en)
|
1995-07-31 |
2005-11-30 |
Urocor, Inc. |
Biomarkers and targets for diagnosis, prognosis and management of prostate disease
|
|
US6218529B1
(en)
|
1995-07-31 |
2001-04-17 |
Urocor, Inc. |
Biomarkers and targets for diagnosis, prognosis and management of prostate, breast and bladder cancer
|
|
US5675024A
(en)
|
1995-11-22 |
1997-10-07 |
Allergan |
Aryl or heteroaryl amides of tetrahydronaphthalene, chroman, thiochroman and 1,2,3,4,-tetrahydroquinoline carboxylic acids, having an electron withdrawing substituent in the aromatic or heteroaromatic moiety, having retinoid-like biological activity
|
|
US5663357A
(en)
|
1995-11-22 |
1997-09-02 |
Allergan |
Substituted heteroarylamides having retinoid-like biological activity
|
|
AU703203B2
(en)
|
1996-01-30 |
1999-03-18 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
|
CA2249665A1
(en)
|
1996-04-03 |
1997-10-09 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
|
WO1997036585A1
(en)
|
1996-04-03 |
1997-10-09 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
|
AU716381B2
(en)
|
1996-04-03 |
2000-02-24 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
|
AU2381397A
(en)
|
1996-04-19 |
1997-11-12 |
Novo Nordisk A/S |
Modulators of molecules with phosphotyrosine recognition units
|
|
US6057122A
(en)
|
1996-05-03 |
2000-05-02 |
Abbott Laboratories |
Antiangiogenic peptides polynucleotides encoding same and methods for inhibiting angiogenesis
|
|
JP2000511558A
(ja)
|
1996-06-21 |
2000-09-05 |
アラーガン・セイルズ・インコーポレイテッド |
レチノイドおよび／またはレチノイド拮抗剤様生物学的活性を有する置換テトラヒドロナフタレンおよびジヒドロナフタレン誘導体
|
|
US6268308B1
(en)
|
1996-08-27 |
2001-07-31 |
Syngenta Crop Protection, Inc. |
Herbicidal S-substituted 1,2,4,6-thiatriazines
|
|
TW523506B
(en)
|
1996-12-18 |
2003-03-11 |
Ono Pharmaceutical Co |
Sulfonamide or carbamide derivatives and drugs containing the same as active ingredients
|
|
AU730224B2
(en)
|
1996-12-23 |
2001-03-01 |
Du Pont Pharmaceuticals Company |
Nitrogen containing heteroaromatics as factor Xa inhibitors
|
|
US6020357A
(en)
|
1996-12-23 |
2000-02-01 |
Dupont Pharmaceuticals Company |
Nitrogen containing heteroaromatics as factor Xa inhibitors
|
|
US6306393B1
(en)
|
1997-03-24 |
2001-10-23 |
Immunomedics, Inc. |
Immunotherapy of B-cell malignancies using anti-CD22 antibodies
|
|
US6723719B1
(en)
*
|
1997-04-25 |
2004-04-20 |
Pfizer Inc |
Pyrazolopyrimidinones which inhibit type 5 cyclic guanosine 3′,5′—monophosphate phosphodiesterase (cGMP PDE5) for the treatment of sexual dysfunction
|
|
EP1019394A1
(en)
*
|
1997-05-22 |
2000-07-19 |
G.D. Searle & Co. |
PYRAZOLE DERIVATIVES AS p38 KINASE INHIBITORS
|
|
SK174699A3
(en)
|
1997-06-19 |
2000-08-14 |
Du Pont Pharm Co |
Inhibitors of factor xa with a neutral p1 specificity group
|
|
PL342447A1
(en)
|
1997-10-27 |
2001-06-04 |
Agouron Pharma |
Substituted 4-amino thiazol-2-yl compounds as inhibitors of cyclin-dependent kinases
|
|
ATE260103T1
(de)
|
1997-12-19 |
2004-03-15 |
Schering Ag |
Ortho-anthranilamide derivate als antikoagulantien
|
|
EP1042299A1
(en)
|
1997-12-22 |
2000-10-11 |
Du Pont Pharmaceuticals Company |
Nitrogen containing heteroaromatics with ortho-substituted p1's as factor xa inhibitors
|
|
WO1999067235A1
(en)
|
1998-06-25 |
1999-12-29 |
Sumitomo Pharmaceuticals Co., Ltd. |
Five-membered ring compounds
|
|
WO2000006169A1
(en)
|
1998-07-29 |
2000-02-10 |
Merck & Co., Inc. |
Integrin receptor antagonists
|
|
JP2000186092A
(ja)
|
1998-12-22 |
2000-07-04 |
Kyowa Hakko Kogyo Co Ltd |
Ｕｃｎ−０１の製造法
|
|
CA2348740A1
(en)
|
1998-12-23 |
2000-07-06 |
Ruth R. Wexler |
Thrombin or factor xa inhibitors
|
|
EP1175419B1
(en)
|
1999-04-02 |
2003-05-28 |
Bristol-Myers Squibb Pharma Company |
Aryl sulfonyls as factor xa inhibitors
|
|
EP1169038B9
(en)
|
1999-04-15 |
2013-07-10 |
Bristol-Myers Squibb Company |
Cyclic protein tyrosine kinase inhibitors
|
|
US6166244A
(en)
|
1999-05-07 |
2000-12-26 |
Allergan Sales, Inc. |
Oxygen, sulfur and nitrogen substituted cyclohexene and cyclohexane derivatives having retinoid-like biological activity
|
|
AU5284000A
(en)
|
1999-05-24 |
2000-12-12 |
Cor Therapeutics, Inc. |
Inhibitors of factor xa
|
|
FR2795726A1
(fr)
|
1999-06-30 |
2001-01-05 |
Aventis Cropscience Sa |
Nouveaux pyrazoles fongicides
|
|
PE20010306A1
(es)
|
1999-07-02 |
2001-03-29 |
Agouron Pharma |
Compuestos de indazol y composiciones farmaceuticas que los contienen utiles para la inhibicion de proteina kinasa
|
|
US6127382A
(en)
|
1999-08-16 |
2000-10-03 |
Allergan Sales, Inc. |
Amines substituted with a tetrahydroquinolinyl group an aryl or heteroaryl group and an alkyl group, having retinoid-like biological activity
|
|
US6093838A
(en)
|
1999-08-16 |
2000-07-25 |
Allergan Sales, Inc. |
Amines substituted with a dihydro-benzofuranyl or with a dihydro-isobenzofuranyl group, an aryl or heteroaryl group and an alkyl group, having retinoid-like biological activity
|
|
AU6936500A
(en)
|
1999-08-24 |
2001-03-19 |
Regents Of The University Of California, The |
Non-quinoline inhibitors of malaria parasites
|
|
CZ2002959A3
(cs)
|
1999-09-17 |
2002-07-17 |
Millennium Pharmaceuticals, Inc. |
Inhibitory faktoru Xa
|
|
ES2316383T3
(es)
|
1999-09-17 |
2009-04-16 |
Millennium Pharmaceuticals, Inc. |
Benzamidas e inhibidores relacionados del factor xa.
|
|
US6632815B2
(en)
|
1999-09-17 |
2003-10-14 |
Millennium Pharmaceuticals, Inc. |
Inhibitors of factor Xa
|
|
JP2003513075A
(ja)
|
1999-11-05 |
2003-04-08 |
スミスクライン ビーチャム パブリック リミテッド カンパニー |
複合５ｈｔ１ａ、５ｈｔ１ｂおよび５ｈｔ１ｄ受容体活性を有するイソキノリンおよびキナゾリン誘導体
|
|
YU54202A
(sh)
|
2000-01-18 |
2006-01-16 |
Agouron Pharmaceuticals Inc. |
Jedinjenja indazola, farmaceutske smeše i postupci za stimulisanje i inhibiranje ćelijske proliferacije
|
|
HN2001000008A
(es)
|
2000-01-21 |
2003-12-11 |
Inc Agouron Pharmaceuticals |
Compuesto de amida y composiciones farmaceuticas para inhibir proteinquinasas, y su modo de empleo
|
|
EP1259887A4
(en)
|
2000-01-25 |
2003-08-13 |
Vistaprint Usa Inc |
Managing print jobs
|
|
KR20010111298A
(ko)
|
2000-02-05 |
2001-12-17 |
버텍스 파마슈티칼스 인코포레이티드 |
Ｅｒｋ의 억제제로서 유용한 피라졸 조성물
|
|
WO2001058869A2
(en)
|
2000-02-11 |
2001-08-16 |
Bristol-Myers Squibb Company |
Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators in treating respiratory and non-respiratory diseases
|
|
WO2001064642A2
(en)
|
2000-02-29 |
2001-09-07 |
Cor Therapeutics, Inc. |
Benzamides and related inhibitors of factor xa
|
|
AU2001241128A1
(en)
|
2000-03-14 |
2001-09-24 |
Fujisawa Pharmaceutical Co. Ltd. |
Novel amide compounds
|
|
MY138097A
(en)
|
2000-03-22 |
2009-04-30 |
Du Pont |
Insecticidal anthranilamides
|
|
US6613917B1
(en)
|
2000-03-23 |
2003-09-02 |
Allergan, Inc. |
Amines substituted with a dihydronaphthalenyl, chromenyl, or thiochromenyl group, an aryl or heteroaryl group and an alkyl group, having retinoid-like biological activity
|
|
CN100355751C
(zh)
|
2000-03-29 |
2007-12-19 |
西克拉塞尔有限公司 |
2－取代的4－杂芳基－嘧啶、其组合物及其用途
|
|
MXPA02010222A
(es)
*
|
2000-04-18 |
2003-05-23 |
Agouron Pharma |
Pirazoles para inhibir proteina cinasa.
|
|
WO2001081345A1
(en)
|
2000-04-20 |
2001-11-01 |
Mitsubishi Pharma Corporation |
Aromatic amide compounds
|
|
JP2004507455A
(ja)
|
2000-04-25 |
2004-03-11 |
ブリストル−マイヤーズ スクイブ カンパニー |
サイクリン依存性キナーゼ阻害剤としての、５−チオ−、スルフィニル−およびスルホニルピラゾロ［３，４−ｂ］−ピリジンの用途
|
|
WO2001081316A2
(en)
|
2000-04-27 |
2001-11-01 |
Abbott Laboratories |
Substituted phenyl farnesyltransferase inhibitors
|
|
US6414013B1
(en)
|
2000-06-19 |
2002-07-02 |
Pharmacia & Upjohn S.P.A. |
Thiophene compounds, process for preparing the same, and pharmaceutical compositions containing the same background of the invention
|
|
AU2001273040A1
(en)
|
2000-06-27 |
2002-01-08 |
Du Pont Pharmaceuticals Company |
Factor xa inhibitors
|
|
BR0112856A
(pt)
|
2000-07-31 |
2003-07-01 |
Smithkline Beecham Plc |
Método para o tratamento dos distúrbios, composto ou um sal ou solvato deste, processo para a preparação dos mesmos, composição farmacêutico, método de tratamento e/ou profilaxia de um ou mais dos distúrbios, uso de um composto, e, método para o tratamento de diabetes, grande depressão, depressão manìaca, ansiedade, esquizofrenia e distúrbios do sono, em mamìferos humanos e não humanos
|
|
NZ523656A
(en)
*
|
2000-08-31 |
2004-11-26 |
Pfizer Prod Inc |
Pyrazole derivatives and their use as protein kinase inhibitors
|
|
WO2002022605A1
(en)
|
2000-09-15 |
2002-03-21 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compounds useful as protein kinase inhibitors
|
|
AU2001212168A1
(en)
|
2000-10-20 |
2002-05-06 |
Bristol-Myers Squibb Pharma Company |
Acylsemicarbazides and their use as cyclin dependent kinase (CDK) inhibitors
|
|
US6455559B1
(en)
*
|
2001-07-19 |
2002-09-24 |
Pharmacia Italia S.P.A. |
Phenylacetamido-pyrazole derivatives, process for their preparation and their use as antitumor agents
|
|
US6989385B2
(en)
|
2000-12-21 |
2006-01-24 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compounds useful as protein kinase inhibitors
|
|
DE10064823A1
(de)
|
2000-12-22 |
2002-06-27 |
Knoll Ag |
Integrinrezeptorliganden
|
|
US7105682B2
(en)
*
|
2001-01-12 |
2006-09-12 |
Amgen Inc. |
Substituted amine derivatives and methods of use
|
|
US6878714B2
(en)
|
2001-01-12 |
2005-04-12 |
Amgen Inc. |
Substituted alkylamine derivatives and methods of use
|
|
US6995162B2
(en)
*
|
2001-01-12 |
2006-02-07 |
Amgen Inc. |
Substituted alkylamine derivatives and methods of use
|
|
GB0102687D0
(en)
|
2001-02-02 |
2001-03-21 |
Pharmacia & Upjohn Spa |
Oxazolyl-pyrazole derivatives active as kinase inhibitors,process for their preparation and pharmaceutical compositions comprising them
|
|
MY130778A
(en)
|
2001-02-09 |
2007-07-31 |
Vertex Pharma |
Heterocyclic inhibitiors of erk2 and uses thereof
|
|
CN1492758A
(zh)
|
2001-02-28 |
2004-04-28 |
C���ֶ� |
抗肿瘤和抗转移作用的方法和制剂
|
|
ES2364550T3
(es)
|
2001-03-05 |
2011-09-06 |
E. I. Du Pont De Nemours And Company |
Agentes de control de plagas de invertebrados de diamidas heterocíclicas.
|
|
DE10110750A1
(de)
|
2001-03-07 |
2002-09-12 |
Bayer Ag |
Neuartige Aminodicarbonsäurederivate mit pharmazeutischen Eigenschaften
|
|
GB0106661D0
(en)
*
|
2001-03-16 |
2001-05-09 |
Pfizer Ltd |
Pharmaceutically active compounds
|
|
WO2002074312A1
(en)
*
|
2001-03-16 |
2002-09-26 |
Pfizer Limited |
Pyrazolo`4,3-d.pyrimidinone compounds as cgmp pde inhibitors
|
|
JPWO2002074298A1
(ja)
|
2001-03-21 |
2004-07-08 |
小野薬品工業株式会社 |
Ｉｌ−６産生阻害剤
|
|
CN1289471C
(zh)
|
2001-04-16 |
2006-12-13 |
先灵公司 |
作为cxc－趋化因子受体配体的3,4－二取代的环丁烯－1,2－二酮
|
|
US6905669B2
(en)
|
2001-04-24 |
2005-06-14 |
Supergen, Inc. |
Compositions and methods for reestablishing gene transcription through inhibition of DNA methylation and histone deacetylase
|
|
US6989245B2
(en)
|
2001-05-11 |
2006-01-24 |
The Burnham Institute |
Screening, diagnostic and therapeutic methods relating to RIZ
|
|
WO2002094183A2
(en)
|
2001-05-18 |
2002-11-28 |
Tap Pharmaceutical Products Inc. |
A method for tumor treatment with fumagillol derivatives
|
|
RU2299198C2
(ru)
|
2001-05-21 |
2007-05-20 |
Е.И.Дюпон Де Немур Энд Компани |
Диамиды антраниловой кислоты, способ борьбы с насекомыми, композиция для борьбы с насекомыми
|
|
US20030236198A1
(en)
|
2001-06-13 |
2003-12-25 |
Genesoft, Inc. |
Antipathogenic benzamide compounds
|
|
EP1423380B1
(en)
|
2001-08-03 |
2010-12-15 |
Vertex Pharmaceuticals Incorporated |
Pyrazole-derived kinase inhibitors and uses thereof
|
|
WO2003011287A1
(en)
|
2001-08-03 |
2003-02-13 |
Vertex Pharmaceuticals Incorporated |
Pyrazolon derivatives as inhibitors of gsk-3
|
|
US20030078232A1
(en)
|
2001-08-08 |
2003-04-24 |
Elfatih Elzein |
Adenosine receptor A3 agonists
|
|
AUPR738301A0
(en)
|
2001-08-30 |
2001-09-20 |
Starpharma Limited |
Chemotherapeutic agents
|
|
CA2457922A1
(en)
|
2001-08-31 |
2003-03-13 |
University Of Connecticut |
Novel pyrazole analogs acting on cannabinoid receptors
|
|
CN101851173A
(zh)
|
2001-09-14 |
2010-10-06 |
梅特希尔基因公司 |
组蛋白脱乙酰化酶抑制剂
|
|
JP2005505595A
(ja)
|
2001-10-12 |
2005-02-24 |
シェーリング コーポレイション |
Ｃｘｃ−ケモカインレセプターアンタゴニストとしての３，４−二置換マレイミド化合物
|
|
HN2002000317A
(es)
*
|
2001-11-02 |
2003-05-21 |
Pfizer |
Inhibidores de pde9 para tratamiento de trastornos cardiovasculares
|
|
CA2466375A1
(en)
|
2001-11-08 |
2003-05-15 |
Pharmacia & Upjohn Company |
Azabicyclic-substituted-heteroaryl compounds for the treatment of disease
|
|
WO2003048081A2
(en)
|
2001-12-04 |
2003-06-12 |
Bristol-Myers Squibb Company |
Glycinamides as factor xa inhibitors
|
|
US20030166932A1
(en)
|
2002-01-04 |
2003-09-04 |
Beard Richard L. |
Amines substituted with a dihydronaphthalenyl, chromenyl, or thiochromenyl group, an aryl or heteroaryl group and an alkyl group, having retinoid-like biological activity
|
|
MXPA04005939A
(es)
|
2002-01-22 |
2005-01-25 |
Warner Lambert Co |
2-(piridin-2-ilamino)-pirido[2,3-d]pirimidin-7-onas.
|
|
US7205307B2
(en)
|
2002-02-14 |
2007-04-17 |
Icagen, Inc. |
Pyrimidines as novel openers of potassium ion channels
|
|
CN101259120B
(zh)
|
2002-03-04 |
2012-07-04 |
Hdac默克研究有限责任公司 |
辛二酰苯胺异羟肟酸或其可药用盐在制备诱导末期分化的药物的用途
|
|
EP1485093B1
(en)
|
2002-03-12 |
2010-11-03 |
Merck Sharp & Dohme Corp. |
Di-aryl substituted tetrazole modulators of metabotropic glutamate receptor-5
|
|
ATE478872T1
(de)
*
|
2002-03-28 |
2010-09-15 |
Ustav Ex Botan Av Cr V V I I O |
Pyrazoloä4,3-düpyrimidine, verfahren zu ihrer herstellung und therapeutische anwendung
|
|
US6995168B2
(en)
|
2002-05-31 |
2006-02-07 |
Euro-Celtique S.A. |
Triazaspiro compounds useful for treating or preventing pain
|
|
AU2003249369A1
(en)
|
2002-06-21 |
2004-01-06 |
Cellular Genomics, Inc. |
Certain amino-substituted monocycles as kinase modulators
|
|
ATE425753T1
(de)
|
2002-08-02 |
2009-04-15 |
Genesoft Pharmaceuticals Inc |
Biaryl-verbindungen mit antiinfektiver wirkung
|
|
GB0218625D0
(en)
|
2002-08-10 |
2002-09-18 |
Astex Technology Ltd |
Pharmaceutical compounds
|
|
MY133311A
(en)
|
2002-09-19 |
2007-11-30 |
Schering Corp |
Novel imidazopyridines as cyclin dependent kinase inhibitors
|
|
US6737382B1
(en)
|
2002-10-23 |
2004-05-18 |
Nippon Soda Co. Ltd. |
Insecticidal aminothiazole derivatives
|
|
WO2004039795A2
(en)
|
2002-10-29 |
2004-05-13 |
Fujisawa Pharmaceutical Co., Ltd. |
Amide compounds for the treatment of hyperlipidemia
|
|
US20050026877A1
(en)
|
2002-12-03 |
2005-02-03 |
Novacea, Inc. |
Pharmaceutical compositions comprising active vitamin D compounds
|
|
US7202257B2
(en)
|
2003-12-24 |
2007-04-10 |
Deciphera Pharmaceuticals, Llc |
Anti-inflammatory medicaments
|
|
US7144911B2
(en)
|
2002-12-31 |
2006-12-05 |
Deciphera Pharmaceuticals Llc |
Anti-inflammatory medicaments
|
|
KR101076018B1
(ko)
|
2003-01-08 |
2011-10-21 |
유니버시티 오브 워싱톤 |
항균제
|
|
US7169797B2
(en)
|
2003-02-14 |
2007-01-30 |
Abbott Laboratories |
Protein-tyrosine phosphatase inhibitors and uses thereof
|
|
US7320989B2
(en)
*
|
2003-02-28 |
2008-01-22 |
Encysive Pharmaceuticals, Inc. |
Pyridine, pyrimidine, quinoline, quinazoline, and naphthalene urotensin-II receptor antagonists
|
|
TW200505902A
(en)
|
2003-03-20 |
2005-02-16 |
Schering Corp |
Cannabinoid receptor ligands
|
|
EP2385041B1
(en)
|
2003-05-01 |
2013-09-18 |
Bristol-Myers Squibb Company |
Pyrazole-amine compounds useful as kinase inhibitors
|
|
WO2004099127A1
(en)
|
2003-05-07 |
2004-11-18 |
Novo Nordisk A/S |
Novel compounds as kinase inhibitors
|
|
MXPA05012081A
(es)
|
2003-05-09 |
2006-02-22 |
Pharmacia & Upjohn Co Llc |
Derivados de pirimidina sustituidos.
|
|
WO2005000309A2
(en)
|
2003-06-27 |
2005-01-06 |
Ionix Pharmaceuticals Limited |
Chemical compounds
|
|
WO2005000356A1
(ja)
|
2003-06-27 |
2005-01-06 |
Ono Pharmaceutical Co., Ltd. |
尿路疾患治療剤
|
|
TWI372050B
(en)
*
|
2003-07-03 |
2012-09-11 |
Astex Therapeutics Ltd |
(morpholin-4-ylmethyl-1h-benzimidazol-2-yl)-1h-pyrazoles
|
|
CA2532965C
(en)
*
|
2003-07-22 |
2013-05-14 |
Astex Therapeutics Limited |
3, 4-disubstituted 1h-pyrazole compounds and their use as cyclin dependent kinases (cdk) and glycogen synthase kinase-3 (gsk-3) modulators
|
|
SE0303396D0
(sv)
|
2003-12-16 |
2003-12-16 |
Astrazeneca Ab |
Chemical compounds
|
|
EP1718306A2
(en)
|
2004-02-20 |
2006-11-08 |
Chiron Corporation |
Modulation of inflammatory and metastatic processes
|
|
EA012451B1
(ru)
|
2004-03-11 |
2009-10-30 |
4Сц Аг |
Новые амидозамещённые гидрокси-6-фенилфенантридины
|
|
US20060084691A1
(en)
|
2004-10-18 |
2006-04-20 |
Bilal Piperdi |
Combined treatment with bortezomib and an epidermal growth factor receptor kinase inhibitor
|
|
MX2007008781A
(es)
*
|
2005-01-21 |
2007-09-11 |
Astex Therapeutics Ltd |
Compuestos farmaceuticos.
|
|
US20080139620A1
(en)
*
|
2005-01-21 |
2008-06-12 |
Astex Therapeutics Limited |
Pyrazole Derivatives For The Inhibition Of Cdk's And Gsk's
|
|
EP1845975A1
(en)
*
|
2005-01-21 |
2007-10-24 |
Astex Therapeutics Limited |
Combinations of pyrazole kinase inhibitors and further antitumor agents
|
|
AR054425A1
(es)
|
2005-01-21 |
2007-06-27 |
Astex Therapeutics Ltd |
Sales de adicion de piperidin 4-il- amida de acido 4-(2,6-dicloro-benzoilamino) 1h-pirazol-3-carboxilico.
|
|
US8404718B2
(en)
|
2005-01-21 |
2013-03-26 |
Astex Therapeutics Limited |
Combinations of pyrazole kinase inhibitors
|
|
AR053662A1
(es)
*
|
2005-01-21 |
2007-05-16 |
Astex Therapeutics Ltd |
Compuestos de pirazol inhibidores de la actividad quinasa cdk y gsk
|
|
CN101146532B
(zh)
*
|
2005-01-21 |
2012-05-09 |
阿斯泰克斯治疗有限公司 |
药物化合物
|
|
WO2008007113A2
(en)
|
2006-07-14 |
2008-01-17 |
Astex Therapeutics Limited |
Pharmaceutical combinations
|
|
US20090318500A1
(en)
|
2006-05-05 |
2009-12-24 |
Astex Therapeutics Limited |
4-(2, 6-Dichloro-benzoylamino)-1H-pyrazole-3-carboxylic acid (1-methanesulphonyl-piperidin-4-yl)-amide for the Treatment of Cancer
|
|
US20090142337A1
(en)
*
|
2006-05-08 |
2009-06-04 |
Astex Therapeutics Limited |
Pharmaceutical Combinations of Diazole Derivatives for Cancer Treatment
|
|
EP2043635A2
(en)
|
2006-06-29 |
2009-04-08 |
Astex Therapeutics Limited |
Pharmaceutical combinations
|
|
EP2046330A2
(en)
|
2006-07-14 |
2009-04-15 |
Astex Therapeutics Limited |
Pharmaceutical combinations
|
|
JP2009543771A
(ja)
|
2006-07-14 |
2009-12-10 |
アステックス・セラピューティクス・リミテッド |
医薬化合物
|
|
WO2008009954A1
(en)
|
2006-07-21 |
2008-01-24 |
Astex Therapeutics Limited |
Medical use of cyclin dependent kinases inhibitors
|
|
WO2008044041A1
(en)
|
2006-10-12 |
2008-04-17 |
Astex Therapeutics Limited |
Pharmaceutical combinations
|